Vertex Pharmaceuticals
S&P 500
Nasdaq 100
$515.44
+0.17%
Delayed · cached 15 min
Frequently asked questions
What sector does Vertex Pharmaceuticals belong to?
Vertex Pharmaceuticals operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of VRTX?
As of the latest available quote, VRTX traded at $515.44. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of VRTX?
Vertex Pharmaceuticals has a price-to-earnings (P/E) ratio of about 30.04. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of VRTX?
The market capitalisation of Vertex Pharmaceuticals is approximately $133.01B.
Is Vertex Pharmaceuticals profitable?
For its latest reported financial year, Vertex Pharmaceuticals recorded a net profit margin of about 32.94%.
Does VRTX pay a dividend?
Vertex Pharmaceuticals does not currently show a dividend yield in our data.
What is the return on equity (ROE) of VRTX?
Vertex Pharmaceuticals has a return on equity (ROE) of about 19.52%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of VRTX?
Over the past 52 weeks, VRTX has traded between a low of $374.17 and a high of $560.25.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.